CD16
| Aliases: | CD16, CD16A, FCG3, FCGR3, FCGRIII, FCR-10, FCRIII, FCRIIIA, IGFR3, IMD20 |
|---|---|
| Other: | low affinity immunoglobulin gamma Fc region receptor III-A|CD16a antigen|Fc fragment of IgG, low affinity III, receptor for (CD16)|Fc fragment of IgG, low affinity IIIa, receptor (CD16a)|Fc gamma receptor III-A|Fc-gamma RIII-alpha|Fc-gamma receptor III-2 (CD 16)|Fc-gamma receptor IIIb (CD16)|FcgammaRIIIA|igG Fc receptor III-2|immunoglobulin G Fc receptor III|low affinity immunoglobulin gamma receptor III-a Fc fragment|neutrophil-specific antigen NA |
This gene encodes a receptor for the Fc portion of immunoglobulin G, and it is involved in the removal of antigen-antibody complexes from the circulation, as well as other responses, including antibody dependent cellular mediated cytotoxicity and antibody dependent enhancement of virus infections. This gene (FCGR3A) is highly similar to another nearby gene (FCGR3B) located on chromosome 1. The ... see more
Vio Bright 515
| Common Laser: | 488 |
|---|---|
| Common Filter: | 525/50 |
| Excitation Peak: | 488 |
| Emission Peak: | 514 |
Vio®Bright® B515 from Miltenyi has an excitation peak at 488 nm and an emission peak at 514. It is comparable to BB515 in flow cytometry.
Popular CD16 Vio Bright 515 Antibodies
| Company / SKU |
Applications | Marker / Reactivity |
Host / Isotype / Clone |
Size / Price |
Details | |
|---|---|---|---|---|---|---|
|
Miltenyi Biotec 130-110-409 |
FC | CD16 Human,Non-Human Primate |
Recombinant IgG1 REA423 |
30 Tests $166 |
Details | |
|
Miltenyi Biotec 130-119-616 |
FC,MICS (MACSima Imaging Cyclic Staining),IF,IHC,Mass Cytometry | CD16 Human |
Human IgG1 REA423 |
100 tests in 200 µL $485 |
Details | |
|
Miltenyi Biotec 130-119-706 |
FC,MICS (MACSima Imaging Cyclic Staining),IF,IHC,Mass Cytometry | CD16 Human |
Human IgG1 REA423 |
30 tests in 60 µL $195 |
Details | |
|
Miltenyi Biotec 130-110-308 |
FC | CD16 Human,Non-Human Primate |
Recombinant IgG1 REA423 |
100 Tests $415 |
Details | |
| Browse CD16 / Vio Bright 515 antibodies. | ||||||

